Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
about
Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection.Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses.Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase.Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.Human papillomavirus infection among young adolescents in India: impact of vaccination.Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study.Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis.
P2860
Q33503893-58AAE704-A5A0-47E3-8B1F-6F24422EB99DQ33803013-7B5A5A1A-85ED-4E9F-A9A0-7BA3F0A57447Q34995160-64339D08-DE7F-49A0-A997-38A00EE85EF4Q36360128-7844497E-EF13-49E0-9D79-2B4E83212A59Q36497960-257BB7B8-6B05-4F41-92BA-9A5A6D19747BQ36982644-9E8250FE-24A6-4F77-A4A8-CEC7F3F4E42BQ37623125-5D206B61-C015-476C-9323-F73BF0F7569CQ38864853-DEC6D411-3FA3-4E37-A9AB-67EAC47943C2Q40073405-F69BCFAB-CC9E-4CA0-9D3C-558B7E2EF4BBQ45392523-07014995-FAC8-4159-A5D6-956386318517Q49779572-5059FE9E-88A0-417F-8DD5-9F31679507FAQ53281416-AEF4D98E-354B-4043-AE36-331A28AC744BQ53519290-548AFEAE-02EF-4BD6-9752-77DC6695FE7FQ54431224-DFE379F4-6C18-47A8-9903-AE1578C81515
P2860
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Telomerase activity as an adju ...... screening in cervical cancer.
@ast
Telomerase activity as an adju ...... screening in cervical cancer.
@en
type
label
Telomerase activity as an adju ...... screening in cervical cancer.
@ast
Telomerase activity as an adju ...... screening in cervical cancer.
@en
prefLabel
Telomerase activity as an adju ...... screening in cervical cancer.
@ast
Telomerase activity as an adju ...... screening in cervical cancer.
@en
P2093
P2860
P356
P1476
Telomerase activity as an adju ...... screening in cervical cancer.
@en
P2093
C C Soundararajan
S Vivekanandhan
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603375
P407
P577
2006-10-24T00:00:00Z